2
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          At the time of the first wave of the COVID-19 pandemic in Sweden, little was known about how effective our regular end-of-life care strategies would be for patients dying from COVID-19 in hospitals. The aim of the study was to describe and evaluate end-of-life care for patients dying from COVID-19 in hospitals in Sweden up until up until 12 November 2020.

          Methods

          Data were collected from the Swedish Register of Palliative Care. Hospital deaths during 2020 for patients with COVID-19 were included and compared to a reference cohort of hospital patients who died during 2019. Logistic regression was used to compare the groups and to control for impact of sex, age and a diagnosis of dementia.

          Results

          The COVID-19 group (1476 individuals) had a lower proportion of women and was older compared to the reference cohort (13,158 individuals), 81.8 versus 80.6 years ( p < .001). Breathlessness was more commonly reported in the COVID-19 group compared to the reference cohort (72% vs 43%, p < .001). Furthermore, anxiety and delirium were more commonly and respiratory secretions, nausea and pain were less commonly reported during the last week in life in the COVID-19 group ( p < .001 for all five symptoms). When present, complete relief of anxiety ( p = .021), pain ( p = .025) and respiratory secretions ( p = .037) was more often achieved in the COVID-19 group. In the COVID-19 group, 57% had someone present at the time of death compared to 77% in the reference cohort ( p < .001).

          Conclusions

          The standard medical strategies for symptom relief and end-of-life care in hospitals seemed to be acceptable. Symptoms in COVID-19 deaths in hospitals were relieved as much as or even to a higher degree than in hospitals in 2019. Importantly, though, as a result of closing the hospitals to relatives and visitors, patients dying from COVID-19 more frequently died alone, and healthcare providers were not able to substitute for absent relatives.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          What we know so far: COVID-19 current clinical knowledge and research.

          Mary Lake (2020)
          In December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

            In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020. We detail the first European cases. As at 21 February, nine European countries reported 47 cases. Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China. Median case age was 42 years; 25 were male. Late detection of the clusters’ index cases delayed isolation of further local cases. As at 5 March, there were 4,250 cases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey

              Purpose To survey healthcare workers (HCW) on availability and use of personal protective equipment (PPE) caring for COVID-19 patients in the intensive care unit (ICU). Materials and method A web-based survey distributed worldwide in April 2020. Results We received 2711 responses from 1797 (67%) physicians, 744 (27%) nurses, and 170 (6%) Allied HCW. For routine care, most (1557, 58%) reportedly used FFP2/N95 masks, waterproof long sleeve gowns (1623; 67%), and face shields/visors (1574; 62%). Powered Air-Purifying Respirators were used routinely and for intubation only by 184 (7%) and 254 (13%) respondents, respectively. Surgical masks were used for routine care by 289 (15%) and 47 (2%) for intubations. At least one piece of standard PPE was unavailable for 1402 (52%), and 817 (30%) reported reusing single-use PPE. PPE was worn for a median of 4 h (IQR 2, 5). Adverse effects of PPE were associated with longer shift durations and included heat (1266, 51%), thirst (1174, 47%), pressure areas (1088, 44%), headaches (696, 28%), Inability to use the bathroom (661, 27%) and extreme exhaustion (492, 20%). Conclusions HCWs reported widespread shortages, frequent reuse of, and adverse effects related to PPE. Urgent action by healthcare administrators, policymakers, governments and industry is warranted.
                Bookmark

                Author and article information

                Contributors
                lisa.martinsson@umu.se
                Journal
                BMC Palliat Care
                BMC Palliat Care
                BMC Palliative Care
                BioMed Central (London )
                1472-684X
                1 July 2021
                1 July 2021
                2021
                : 20
                : 102
                Affiliations
                [1 ]GRID grid.12650.30, ISNI 0000 0001 1034 3451, Department of Radiation Sciences, , Umeå University, ; SE-90187 Umeå, Sweden
                [2 ]GRID grid.4714.6, ISNI 0000 0004 1937 0626, Palliative Care Unit, , Stockholms Sjukhem Foundation, ; Stockholm, Sweden
                [3 ]GRID grid.4714.6, ISNI 0000 0004 1937 0626, R & D Department, , Stockholms Sjukhem Foundation, ; Stockholm, Sweden
                [4 ]GRID grid.4714.6, ISNI 0000 0004 1937 0626, Department of Molecular Medicine and Surgery, , Karolinska Institutet, ; Stockholm, Sweden
                [5 ]GRID grid.4714.6, ISNI 0000 0004 1937 0626, Department of Oncology–Pathology, , Karolinska Institutet, ; Stockholm, Sweden
                Author information
                http://orcid.org/0000-0003-4126-2675
                Article
                785
                10.1186/s12904-021-00785-4
                8247619
                34210312
                bf97a642-8027-467e-9e39-f17fafb6c9a5
                © The Author(s) 2021

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 31 March 2021
                : 2 June 2021
                Funding
                Funded by: Swedish Register of Palliative Care
                Funded by: Region Stockholm
                Award ID: ALF project 20200472
                Award Recipient :
                Funded by: Stockholms Sjukhem Foundation’s Jubilee Fund
                Funded by: Region Västerbotten
                Funded by: Umea University
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2021

                Anesthesiology & Pain management
                covid-19,pandemic,palliative care,end-of-life care,hospitals,dementia
                Anesthesiology & Pain management
                covid-19, pandemic, palliative care, end-of-life care, hospitals, dementia

                Comments

                Comment on this article